Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.785
-0.025 (-1.38%)
Oct 7, 2026, 12:30 PM EDT - Market open
Alector Employees
Alector had 103 employees as of December 31, 2025. The number of employees decreased by 135 or -56.72% compared to the previous year. That makes Alector the world's #31,146 largest employer among public companies and #4,003 in the United States.
Employees
103
Change
-135
Growth
-56.72%
Revenue / Employee
$134,592
Profits / Employee
-$1,144,214
Market Cap
199.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | -135 | -56.72% |
| Sep 30, 2025 | 156 | -85 | -35.27% |
| Jun 30, 2025 | 163 | -82 | -33.47% |
| Mar 31, 2025 | 175 | -69 | -28.28% |
| Dec 31, 2024 | 238 | -6 | -2.46% |
| Sep 30, 2024 | 241 | -5 | -2.03% |
| Jun 30, 2024 | 245 | 6 | 2.51% |
| Mar 31, 2024 | 244 | -29 | -10.62% |
| Dec 31, 2023 | 244 | -29 | -10.62% |
| Sep 30, 2023 | 246 | -23 | -8.55% |
| Jun 30, 2023 | 239 | -30 | -11.15% |
| Mar 31, 2023 | 273 | 36 | 15.19% |
| Dec 31, 2022 | 273 | 65 | 31.25% |
| Sep 30, 2022 | 269 | 84 | 45.41% |
| Jun 30, 2022 | 269 | 85 | 46.20% |
| Mar 31, 2022 | 237 | 56 | 30.94% |
| Dec 31, 2021 | 208 | 37 | 21.64% |
| Sep 30, 2021 | 185 | 23 | 14.20% |
| Jun 30, 2021 | 184 | 31 | 20.26% |
| Mar 31, 2021 | 181 | 55 | 43.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Lyell Immunopharma | 161 |
| Nautilus Biotechnology | 127 |
| Keros Therapeutics | 92 |
| Lineage Cell Therapeutics | 77 |
| Compugen | 75 |
| Cartesian Therapeutics | 75 |
ALEC News
- Just now - Alector Press release: Investor update - Filings
- 1 day ago - Alector price target raised to $3 from $2 at Morgan Stanley - TheFly
- 2 days ago - Why is Alector Stock (ALEC) 60% Higher Today? - TipRanks
- 2 days ago - Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion - Reuters
- 2 days ago - Alector enters exclusive AL050 global licensing agreement with Genentech - TheFly
- 2 days ago - Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson's Disease and Other Neurodegenerative Diseases - GlobeNewsWire
- 22 days ago - Alector Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 26 days ago - Alector Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts